I got a text the other day from a friend: “The Yankees need to re-sign Aaron Small and Shawn Chacon.”
It’s a running joke between us, a reference to the 2005 season, when the Yankees were 39-39 on June 1, not looking very good, and Aaron Small and Shawn Chacon popped up out of nowhere to bolster the pitching staff. Small went 10-0 and Chacon went 7-3, the Yankees won 95 games and the team made the playoffs, like it had the previous 10 seasons. Of course, my friend is a Red Sox fan, so it’s not so much a joke as his own personal and painful reminder that the New York Yankees always find a way. Always.
Except this season.
It became clear this weekend that the Yankees will not find a path to the playoffs in 2023 — and, in fact, might not even find the path to a winning season. On Sunday, they led the Marlins 7-3 entering the bottom of the ninth. Clay Holmes and Tommy Kahnle faced eight batters, got only one of them out, and the Marlins rallied for an improbable 8-7 victory. “The mountain gets bigger with every loss,” Holmes said afterward. “We have to put together some wins and string them together and get some momentum going.”
Unfortunately, a series in Atlanta followed. The Braves pounded the Yankees 11-3 on Monday, shut them out 5-0 on one hit on Tuesday and beat them 2-0 on Wednesday. That loss dropped the Yankees to 60-61. It’s the latest in a season they’ve been under .500 since 1995 (nine of the 26 players on the active roster were not yet born). “We’re not showing up, that’s what it comes down to,” Aaron Judge said after the blowout defeat on Monday. “We need to take some personal pride,” said manager Aaron Boone.
For once, the Yankees have no answers. Small or Chacon or Mike Tauchman or Matt Carpenter is not around to rescue them. The rotation is full of injuries. The bullpen is finally leaking. The offense is bad.
Some have rightfully pointed to the Yankees’ lack of left-handed hitting, a major strategic flaw in the roster. The Yankees are next to last in the majors in plate appearances from left-handed batters — despite the obvious reason to employ them and their status as a hallmark of Yankees success going back to Babe Ruth and Lou Gehrig. (Yes, the Astros have the fewest, but the difference: Houston’s right-handed hitters are better.)
Most problematic: For the second time in three years, the overall offense just hasn’t been good. Among the regulars, only Judge and Gleyber Torres carry an OPS+ above league average. The Yankees were 10th in the AL in runs in 2021, first in 2022, 10th again in 2023. We all know what happened last season, but, shockingly, counting on Judge to remain healthy and hit 62 home runs every season probably isn’t a reliable master plan.
Since July 4, when they were 10 games over .500, the Yankees are 12-23 and have been outscored by 51 runs. Over the same period, they are 28th in the majors in runs scored and 24th in runs allowed.
“It’s been a slog,” a frustrated Boone told reporters on Monday. “It’s been a grind. It’s not been how we drew it up.”
They can forget the wild card. The Toronto Blue Jays, currently the third wild-card team, are 12 games over .500. If the Jays play .500 the rest of the way they would finish 87-75, so the Yankees would have to go 27-14 just to tie them — and they also have the Seattle Mariners and Boston Red Sox to climb over. It’s not going to happen — and in fact finishing in last place in the AL East is more likely. But that’s not even the worst part of this year’s trajectory — it could be the franchise’s first losing record since 1992.
The Yankees’ 30-year streak of consecutive winning seasons is an astonishingly impressive achievement in the ultracompetitive business of modern sports. The New England Patriots under Bill Belichick (and with Tom Brady) had 19 consecutive winning seasons from 2001 through 2019. In the NBA, the longest active streak is a mere 12 seasons by, believe it or not, the LA Clippers. The San Antonio Spurs had a 22-year run from 1998 to 2019 but have now suffered four losing seasons in a row. The Pittsburgh Penguins own the longest streak in the NHL at 17 seasons. Even Alabama football has had four losing seasons since the Yankees last had one.
Not surprisingly, a growing percentage of Yankees fans are not only calling for Boone to be fired but longtime general manager Brian Cashman as well. If the team does miss the playoffs and finishes with a losing record, Boone’s seat no doubt will be hot, even though he has another year on his contract. That decision might rest more with managing general partner Hal Steinbrenner than Cashman. Who knows, Steinbrenner might not want to eat Boone’s $2.75 million salary. After all, these Yankees now construct their business with some limitations on expenses — although let’s point out they still have the game’s second-largest payroll in 2023.
That’s why fingers are also pointing in the direction of Cashman, the team’s GM since February of 1998 (who signed a new long-term deal this winter). The Yankees haven’t won a World Series since 2009, but let’s be fair here: While falling short of a title, the Yankees have had success in recent seasons, winning 99 games in 2022, 103 in 2019 and 100 in 2018. They’ve reached three American League Championship Series since 2017, losing all three times to the Astros.
Still, the majority of Cashman’s big decisions in recent years haven’t worked out, even if many of them were defensible at the time. Consider:
Trading for Giancarlo Stanton before the 2018 season. It was too tempting to resist pairing Stanton, coming off a 59-homer season with the Marlins, with Judge, coming off his 52-homer rookie season. Stanton had a 38-homer, 4.4-WAR season in 2018 but has produced less than 1.0 WAR in four of the next five, including 2023, when he’s barely been above replacement level — for a $32 million salary. The ripple effect of the Stanton trade makes it sting even more: With Judge and Stanton, the Yankees stayed away from pursuing Bryce Harper when he hit free agency after the 2018 season, even though Harper grew up a Yankees fan and had a swing tailor-made for the short right-field porch. Since 2019, Stanton has been worth just 4.8 WAR; Harper has racked up 15.8.
Giving Aaron Hicks a seven-year, $70 million extension in 2019 after one good full season in the majors in 2018 (and a good partial season in 2017). At the time, this made some sense since Hicks would be a potential bargain if he continued to play well. But he was an older player for a breakout season, turning 29 at the start of that deal. He battled injuries and played 100 games just once for the Yankees (hitting .216 in 2022) before they released him earlier this season.
Signing DJ LeMahieu to a six-year, $90 million contract in 2021 even though he was entering his age-32 season. LeMahieu was coming off two excellent seasons, finishing fourth in the MVP voting in 2019 and then third in 2020 after hitting .364 and leading the AL in OPS in 50 games during the COVID season. A reasonable signing given LeMahieu’s production those two seasons, it was still risky given his age and, as we now know, a lot of players had fluky numbers in 2019 (due to the juiced ball) and 2020 (due to the weird short season). LeMahieu has been OK, but Cashman would probably like a redo on this one.
Trading for Josh Donaldson in 2022. Another bet on an older player — Donaldson was entering his age-36 season in 2022 — that didn’t work out.
The Frankie Montas trade last year. Montas had missed a couple of starts with the A’s with a sore shoulder, but Cashman traded for him anyway. He went 1-3 with a 6.35 ERA down the stretch, missed the postseason and will miss all of 2023 after shoulder surgery.
Needing a center fielder last year — in part because Hicks was unproductive — the Yankees traded solid starter Jordan Montgomery for Harrison Bader, even though Bader was on the injured list at the time. Bader has missed about 50 games this season and been a below-average hitter, while Montgomery could have been used in the rotation.
Signing Carlos Rodon to a six-year, $162 million contract. It’s obviously too early to assess the long-term value here, but the first year of the deal has been a washout so far, with Rodon winning one game in eight starts with a 7.44 ERA. He’s on the IL right now with a hamstring strain, although he could return next week.
Obviously, not every Cashman deal has backfired — most significantly, Gerrit Cole has been worth the money. In part, Cashman was pushed to gamble on some of those older players because the farm system hasn’t been productive enough. Deivi Garcia was supposed to a rotation stalwart by now, but he was placed on waivers last week (the White Sox claimed him). Luis Gil got injured. Others like Estevan Florial or Albert Abreu just didn’t develop as hoped. Many were scattered to the winds in various transactions — Ezequiel Duran, Garrett Whitlock, Luis Medina, Hayden Wesneski, Roansy Contreras, Kevin Alcantara, Thairo Estrada, JP Sears. The Yankees haven’t really been burned too badly by any of those guys, but what were the returns?
This probably sounds more dire than it is. No matter what happens the rest of 2023, the Yankees will find a way to reshape things for 2024. A rotation with Cole, Rodon and Nestor Cortes is a good starting point, assuming better health from Rodon and Cortes. The lineup needs an overhaul, though, and the Yankees will still be on the hook for $64 million in salaries for Stanton, LeMahieu and Anthony Rizzo (who knows what he’ll be able to contribute given his struggles with post-concussion syndrome). As it was at this year’s trade deadline when the Yankees debated looking for help, the free agent market is thin on hitters — well, you have Shohei Ohtani, but few insiders in the game forecast that happening.
But, that’s all for the offseason, along with the futures of Boone and Cashman. There’s plenty at stake for Yankees fans and Yankees haters alike in these final 41 games: Will the streak come to an end?
Free agent utility man Enrique Hernandez had left elbow surgery Friday for an injury he played through during the Los Angeles Dodgers‘ World Series-winning run.
Hernandez posted about the surgery on Instagram, saying he had played through the injury since May and that it would keep him from playing for Puerto Rico in the World Baseball Classic next year.
He missed more than a month on the injured list during the season due to his elbow but returned in August.
Hernandez, 34, batted .203 with 10 home runs and 35 RBIs in 92 games during the regular season before posting a .250 average with one home run and seven RBIs in the playoffs as the Dodgers won a second straight title.
Members of Congress sent a letter to Major League Baseball commissioner Rob Manfred on Friday, expressing concern over a “new integrity crisis” facing American sports and asking for answers about the alleged betting scheme that led to the recent indictments of two Cleveland Guardians pitchers.
Members of the Senate Committee on Commerce, Science and Transportation, which oversees professional sports, called the allegations against Guardians pitchers Emmanuel Clase and Luis Ortiz “markedly more serious” than other recent betting incidents in baseball. Federal prosecutors on Sunday indicted Clase and Ortiz and accused them of rigging individual pitches over multiple games so gambling associates could profit on wagers.
Sens. Ted Cruz and Maria Cantwell, who lead the committee, questioned why Clase’s alleged actions, which began in May 2023, were not discovered for two years. They contrasted the case with that of former major leaguer Tucupita Marcano, who was banned in 2024 for betting on baseball.
“How did MLB catch Marcano and ban him for life but failed to notice Clase allegedly rigging pitches for two years?” the letter states. “The integrity of the game is paramount. MLB has every interest in ensuring baseball is free from influence and manipulation. … But in light of these recent developments, MLB must clearly demonstrate how it is meeting its responsibility to safeguard America’s pastime.”
The committee members asked when and how MLB was made aware of the alleged activity by Clase and Ortiz and for documentation detailing the league’s betting policies and details of any other betting-related investigations since Jan. 1, 2020. The committee requested the information and documentation by Dec. 5.
ESPN has reached out to MLB for comment. On Monday, MLB announced that its sportsbook partners had agreed to place a $200 limit on all bets involving individual pitches and prohibit such wagers from being included in parlays. The measures were taken to reduce the amount that could be won from pitch-level bets and therefore decrease the incentive of manipulation.
The same committee sent a letter to the NBA in October, asking for information related to that league’s handling of the alleged betting scandal that led to the indictments of Portland Trail Blazers coach Chauncey Billups, former player and coach Damon Jones and Miami Heat veteran guard Terry Rozier.
“An isolated incident of game rigging might be dismissed as an aberration, but the emergence of manipulation across multiple leagues suggests a deeper, systemic vulnerability,” the committee wrote. “These developments warrant thorough scrutiny by Congress before misconduct issues become more widespread.”
Michael Rothstein, based in Atlanta, is a reporter on ESPN’s investigative and enterprise team. You can follow him via Twitter @MikeRothstein.
Testimony in the wrongful death lawsuit against the Los Angeles Angels underscores the difficulties team attorneys face convincing the jury they were unaware of addiction concerns before employee Eric Kay provided a fentanyl-laced pill that killed pitcher Tyler Skaggs in 2019.
The court case, now entering its sixth week, continues to focus on the team’s handling of Kay’s drug addiction treatment and whether officials did enough to protect Skaggs as Kay’s behavior became increasingly strange, causing Kay’s wife and some Angels employees to raise questions of drug abuse.
Kay was present in Skaggs’ hotel room the night he overdosed on alcohol and opioids, less than a month after Kay returned to work from a drug addiction treatment program. In Kay’s 2022 criminal trial, witnesses testified that Kay distributed pills to other players.
The team doctor testified last week that he prescribed more than 600 opioid pills to Kay over several years before learning how addictive the pills could be.
Contradictory testimony by current and former Angels representatives has sharpened scrutiny about what the Angels knew — and whether officials relayed concerns about Kay to Major League Baseball. Among the trial’s key elements in the past two weeks:
Deborah Johnston, the Angels vice president of human resources, testified Monday that the team worked with MLB to address Kay’s addiction, despite her own deposition and previous testimony by other Angels officials saying they had no knowledge of any such coordination.
MLB sent a statement to ESPN denying any knowledge of or involvement in Kay’s treatment. In front of the judge after jurors left the courtroom on Wednesday, the Skaggs family attorneys accused Johnston of committing perjury, a serious allegation. Angels attorneys immediately denied the perjury accusation.
Angels officials testified they believed Kay’s problems came from prescribed medication to address mental health issues, while clubhouse employees testified they either witnessed or believed Kay had a problem with drugs.
Angels officials testified they believed Kay suffered from bipolar disorder even though Kay’s medical records when he entered rehabilitation in April 2019 showed no record of medication to treat bipolar disorder. Kay’s ex-wife, Camela, testified she was not aware of a bipolar diagnosis.
The team doctor, Craig Milhouse, testified that he prescribed Kay 600 pills of the opioids Norco and Vicodin over a 44-month period between 2009 and 2013.
The crux of the case is whether the Angels knew Kay was abusing drugs and providing them to players, including Skaggs while working in his official capacity. Kay is serving 22 years in federal prison for providing the drug that killed Skaggs in a Texas hotel room on July 1, 2019. The team contends he and Skaggs were acting privately in their off time when the overdose occurred.
The plaintiffs claim the Angels put Skaggs in harm’s way by continuing to employ Kay when his behavior showed warning signs of drug abuse. Angels officials say they are not responsible for Skaggs’ death, were not aware of his drug use and that it was Skaggs’ reckless decision to mix alcohol with illicit drugs that killed him. Officials also testified they were not aware Kay was providing drugs to players when Skaggs died.
The Skaggs family is seeking $118 million in estimated lost wages, in addition to potential punitive damages.
Johnston testified last week that the franchise had worked with MLB to get Kay help for his drug addiction. It’s the first time an Angels official suggested MLB was informed of Kay’s problem — a major bone of contention on the question of team responsibility.
Johnston said that when the Angels investigate potential use of illegal substances on team property, one option is immediate termination, depending on the findings. “Another option is to work with MLB, as we did in this case, and with our physician, Dr. [Erik] Abell,” she stated. Abell was the team’s liaison with MLB for such issues.
Johnston also testified that Kay was drug-tested under MLB’s policies, not those of the Angels.
In a text-messaged statement to ESPN about the perjury accusation, Angels’ attorney Todd Theodora wrote: “The accusation that Ms. Johnston committed perjury is completely false and defamatory. Her testimony was truthful based on several text messages she was recently shown demonstrating that Dr. Abell was treating Eric Kay.”
He added that Johnston “did not make any statements about whether Dr. Abell reported this further to MLB.”
An MLB spokesperson denied the league knew of Kay’s drug use or was involved with Kay’s treatment.
In separate weekend comments to ESPN, Theodora and lead plaintiffs attorney Rusty Hardin argued about the perjury issue, with Theodora characterizing the absence of a ruling by the judge on the accusation as a win for his side, while Hardin insisted that no ruling means the issue remains alive — including plaintiffs’ efforts to get MLB testimony.
California-based civil attorney Geoffrey Hickey told ESPN that perjury can only be proven if Johnston “willingly and knowingly” made a false statement under oath. Hickey said Hardin has a “good-faith argument,” but he doesn’t think Johnston’s statements rise to the level of perjury.
Johnston testified in a September pretrial deposition that no one had reported Kay’s drug use to MLB. She explained Monday she “learned additional information” about the Angels’ communications with MLB after giving her deposition. She said she couldn’t remember the exact document where she learned the information.
Kay’s immediate superior, Tim Mead, and the Angels’ traveling secretary, Tom Taylor, testified earlier in the trial that Abell worked with Kay but made no mention of reporting his case to MLB.
Team doctor Milhouse testified that he believed Abell, the team’s sports psychologist, was the liaison to MLB for such an issue. MLB documents state that player drug issues were subject to investigation and disciplinary follow-up by the office of the MLB commissioner.
While Angels officials testified they never saw Kay take illicit drugs, former clubhouse attendant Kris Constanti testified that Kay told him he was taking Norco. Another ex-clubhouse attendant, Vince Willet, testified he saw Kay crush and then snort a pill in the Angels’ clubhouse kitchen during spring training.
Former clubhouse manager Keith Tarter testified that he suspected Kay was using drugs and that Kay told him in 2019 he was concerned because his supply of Suboxone, a drug to treat opioid dependence, was running out. Tarter said he never saw Kay actually use drugs.
Milhouse testified he didn’t learn about the true addictive nature of opioids until 2014 or 2015. He stopped prescribing them for Kay in 2013.
Camela Kay testified that after her ex-husband had a breakdown at Yankees Stadium the same year, he stated in front of Taylor and Mead he was taking five Vicodin a day. Taylor denied it, and Mead said he didn’t recall the conversation. Milhouse also said that during 2009-2013, he typically only prescribed opioids on a short-term basis and that he had put other patients on similar treatment regimens and quantities as Kay. Milhouse testified that he considered the use of opioids five times a day to be an addiction.
The trial continues in Orange County Superior Court this week, with the witness schedule including Skaggs’ widow, Carli, and mother, Debbie Hetman.
Two jurors have already been excused — leaving two alternates for the remainder of the case, which is slated to go to the jury in mid-December.